Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo
Peter J Siska,Jing Jiao,Carina Matos,Katrin Singer,Raffaela S Berger,Katja Dettmer,Peter J Oefner,Michelle D Cully,Zhonglin Wang,William J QuinnIII,Kristen N Oliff,Benjamin J Wilkins,Lanette M Christensen,Liqing Wang,Wayne W Hancock,Joseph A Baur,Matthew H Levine,Ines Ugele,Roman Mayr,Kathrin Renner,Liang Zhou,Marina Kreutz,Ulf H Beier,Peter J. Siska,Raffaela S. Berger,Peter J. Oefner,Michelle D. Cully,William J. QuinnIII,Kristen N. Oliff,Benjamin J. Wilkins,Lanette M. Christensen,Wayne W. Hancock,Joseph A. Baur,Matthew H. Levine,Ulf H. Beier
DOI: https://doi.org/10.1016/j.ebiom.2021.103734
IF: 11.205
2021-12-01
EBioMedicine
Abstract:BACKGROUND: L-kynurenine is a tryptophan-derived immunosuppressive metabolite and precursor to neurotoxic anthranilate and quinolinate. We evaluated the stereoisomer D-kynurenine as an immunosuppressive therapeutic which is hypothesized to produce less neurotoxic metabolites than L-kynurenine.METHODS: L-/D-kynurenine effects on human and murine T cell function were examined in vitro and in vivo (homeostatic proliferation, colitis, cardiac transplant). Kynurenine effects on T cell metabolism were interrogated using [<sup>13</sup>C] glucose, glutamine and palmitate tracing. Kynurenine was measured in tissues from human and murine tumours and kynurenine-fed mice.FINDINGS: We observed that 1 mM D-kynurenine inhibits T cell proliferation through apoptosis similar to L-kynurenine. Mechanistically, [<sup>13</sup>C]-tracing revealed that co-stimulated CD4<sup>+</sup> T cells exposed to L-/D-kynurenine undergo increased β-oxidation depleting fatty acids. Replenishing oleate/palmitate restored effector T cell viability. We administered dietary D-kynurenine reaching tissue kynurenine concentrations of 19 μM, which is close to human kidney (6 μM) and head and neck cancer (14 μM) but well below the 1 mM required for apoptosis. D-kynurenine protected Rag1<sup>-/-</sup> mice from autoimmune colitis in an aryl-hydrocarbon receptor dependent manner but did not attenuate more stringent immunological challenges such as antigen mismatched cardiac allograft rejection.INTERPRETATION: Our dietary kynurenine model achieved tissue concentrations at or above human cancer kynurenine and exhibited only limited immunosuppression. Sub-suppressive kynurenine concentrations in human cancers may limit the responsiveness to indoleamine 2,3-dioxygenase inhibition evaluated in clinical trials.FUNDING: The study was supported by the NIH, the Else Kröner-Fresenius-Foundation, Laffey McHugh foundation, and American Society of Nephrology.
medicine, research & experimental